Related Experiment Video
Updated: Jun 4, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Secondary pulmonary alveolar proteinosis in a patient with chronic myeloid leukemia in the accelerated phase
Ken Ohmachi1, Daisuke Ogiya, Fujiko Morita
1Department of Internal Medicine, Division of Hematology/Oncology, Tokai University 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan. 8jmmd004@is.icc.u-tokai.ac.jp
Abstract:
Pulmonary alveolar proteinosis (PAP) is a rare respiratory disease the character of which is accumulation of protein consisting of surfactant in alveolar spaces. PAP sometimes complicates with hematological malignancies, especially myeloid leukemia. As one of the cause of PAP, impairment of alveolar macrophage is considered. We experienced a case of PAP with chronic myeloid leukemia (CML). 41 years old woman having CML for nine years developed PAP, and was treated by bronchoalveolar lavage and imatinib. She died of respiratory failure in the end, but BAL fluid had been becoming gradually crystalline after induction of imatinib. We consider that we should try to treat to improve respiratory status not only PAP but also hematological disease.
